One page, thousands of outlets. See who else covered it.
Driven by hidden markups and rising drug costs, employers are quietly shifting to smaller alternatives to protect their bottom lines.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.
Nearly 50 life-extending, enriching or saving drugs have cancelled or delayed their Canadian launches in the past year; some of which, were already approved by Health Canada.
New treatments for Huntington's disease could be on the horizon following research led by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab).
Smoking and vaping continued to decline among middle school and high school students in 2025, according to the U.S. Food and Drug Administration's 2025 National Youth Tobacco Survey, released in July…
The Ministry of Health has reaffirmed its commitment to strengthening cancer prevention, early detection and equitable access to treatment while expanding regional capacity for specialised cancer…
Seven large drugmakers and lobbying groups PhRMA and BIO have called upon the German government to revise some of its new drug pricing policies as they back up the US Trade Representative's…
New analytical tools and microbiome-based therapies are pushing the field beyond early hype toward clinical and scientific progress.